Novo Nordisk Brings World’s First Once-Weekly Basal Insulin Awiqli to India
Novo Nordisk has launched Awiqli (insulin icodec), the world’s first once-weekly basal insulin, in India, marking a significant advancement in […]
×
DIABETES-CARE-INDIA
India’s Shift to High-Value, Innovation-Led Pharma: Spotlight on GLP-1
India’s GLP-1 market opened up almost overnight. Semaglutide came off patent in March 2026, and multiple Indian manufacturers launched generics […]
